Stay updated with breaking news from Simulations Plu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ECARX (NASDAQ:ECX – Get Free Report) and Simulations Plus (NASDAQ:SLP – Get Free Report) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Analyst Ratings This is a summary of […]
Firms focus on drug-modeling software.
Simulations Plus, Inc. (NASDAQ:SLP – Get Rating) – Analysts at Oppenheimer boosted their FY2023 earnings per share estimates for shares of Simulations Plus in a research note issued to investors on Thursday, April 6th. Oppenheimer analyst F. Brisebois now forecasts that the technology company will post earnings per share of $0.66 for the year, up […]
Simulations Plus (NASDAQ:SLP – Get Rating)‘s stock had its “outperform” rating reaffirmed by investment analysts at Oppenheimer in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $65.00 price target on the technology company’s stock. Oppenheimer’s price objective would indicate a potential upside of 53.66% from the company’s […]
Drug discovery services partnership with Sino-American Cancer Foundation focuses on the development of actionable hits against the MTHFD2 target ... | March 28, 2023